MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    A case of early onset parkinsonism caused by PLA2G6 gene mutation

    L. Chen, S. Xu (Guangdong, China)

    Objective: To report and follow up a case of early-onset parkinsonism (EOP) caused by mutation of PLA2G6 gene and to improve the understanding and treatment…
  • 2018 International Congress

    Brief Cognitive Screening for Parkinson’s disease by the Korean Version of the Montreal Cognitive Assessment

    M. Park, D. Kwon (Ansan-city, Korea)

    Objective: We evaluated the screening ability of the Korean version of the Montreal Cognitive Assessment (K-MoCA) in the patients with Parkinson's disease. Background: The Montreal…
  • 2018 International Congress

    Quantitative EEG and medial temporal lobe atrophy in early Parkinson’s disease with behavioral and psychological symptoms

    J.Y. Ahn, H.T. Kim (Seoul, Republic of Korea)

    Objective: We aimed to assess the relationship between EEG abnormalities and MTLA, and its clinical validity in Parkinson’s disease with behavioral and psychological symptoms. Background:…
  • 2018 International Congress

    Dopaminergic impairments following repeated exposure to stress on the neurotoxicity of lambda-cyhalothrin through inflammatory cytokines in rats

    R. Shukla, R. Gupta, S. Goel, A. Pant, V. Khanna (Bhopal, India)

    Objective: Impact of psychological stressors in modulating the toxicity of environmental chemicals has been suggested, however the mechanism this is not clear. Background: Repeated stress…
  • 2018 International Congress

    The Development of Interactive, Video-Based Modules for Movement Disorders Education

    S. Schaefer, L. Vadlamani, P. Juthani (New Haven, CT, USA)

    Objective: To design and implement an online, video-based, interactive curriculum in movement disorders for neurology residents. Background: Much of neurology residency is dedicated to inpatient…
  • 2018 International Congress

    A new SPG4/SPAST mutation in an Italian family with hereditary spastic paraplegia and Alzheimer’s disease

    A. Orlacchio, C. Montecchiani, R. Rumore, F. Gaudiello, M. Miele, C. Caltagirone, T. Kawarai (Rome, Italy)

    Objective: To perform a clinical and a genetic study in an Italian family with a complicated form of hereditary spastic paraplegia (HSP) and Alzheimer’s disease…
  • 2018 International Congress

    Perry syndrome: Proposal of international diagnostic criteria and a new disease concept

    T. Mishima, S. Fujioka, H. Tomiyama, I. Yabe, R. Kurisaki, N. Fujii, R. Neshige, O. Ross, M. Farrer, D. Dickson, Z. Wszolek, N. Hattori, Y. Tsuboi (Fukuoka, Japan)

    Objective: To propose international diagnostic criteria for Perry syndrome and a new disease concept. Background: Perry syndrome is a rare autosomal dominant neurodegenerative disease characterised…
  • 2018 International Congress

    Striatal dopamine function in multiple system atrophy and progressive supranuclear palsy: A meta-analysis of imaging studies

    V. Kaasinen, T. Kankare, J. Joutsa, T. Vahlberg (Turku, Finland)

    Objective: To investigate differences in striatal presynaptic dopamine function between multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) using combined data from all available…
  • 2018 International Congress

    Cognition related to striatal dopaminergic function in healthy subjects, in consideration to aging

    H. Li, S. Hirano, S. Furakawa, K. Kojima, K. Shimizu, Y. Nakano, H. Tai, H. Mukai, T. Uno, T. Iimori, H. Matsuda, S. Kuwabara (Chiba, Japan)

    Objective: The aim of the present study was to find the relationship between striatal dopamine transporter (DAT) and cognitive function in healthy subjects and these…
  • 2018 International Congress

    Ginsenoside Rb1 protects dopaminergic neurons through Foxm1-Nurr1 pathway in mice model of Parkinson’s disease

    T. Zhou, X. Huang, L. Li, J. Yang, Z. Liang (Dalian, China)

    Objective: In the present work, we investigated the protective effects of ginsenoside Rb1 in dopaminergic neurons through Foxm1-Nurr1 pathway in mice model of Parkinson’s disease.…
  • « Previous Page
  • 1
  • …
  • 169
  • 170
  • 171
  • 172
  • 173
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An atypical and interesting feature of Parkinson´s disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • #23812 (not found)
  • Approaching Health Care Shaped by Generational Expectations (The AGE Study): Generational Perspective Related to Time
  • Application of the “5-2-1” Screening Criteria in Advanced Parkinson’s Disease Patients Treated with Levodopa-Carbidopa Intestinal Gel: Interim Analysis from the DUOGLOBE Study
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • DaTscan in clinical evaluation of Multiple System Atrophy
  • Decision-making process for opicapone’s bedtime regimen
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley